Terns Pharmaceuticals, Inc. (TERN)
$52.95+0.00%Close
BUYBULL · day 42
Key stats
- Market cap
- $4.8B
- Beta
- -0.38
- P/E (TTM)
- -68.77
- 1W
- +0.04%
- 1M
- +0.74%
- vs SPY 1W
- +0.18%
- vs SPY 1M
- -1.76%
Industry peers
FMP comparable companies · ranked by market cap
- RLAYSELLRelay Therapeutics, Inc.$3.9BRECOVERYQ 2$17.88-3.45%
- AMLXSELLAmylyx Pharmaceuticals, Inc.$3.1BCRISISQ 7$28.14-2.29%
- ELVNSELLEnliven Therapeutics, Inc.$2.9BCRISISQ 11$40.98-3.31%
- PGENBUYPrecigen, Inc.$2.8BBULLQ 9$7.81-2.35%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.5BCRISISQ 15$16.99-15.71%
- INBXSELLInhibrx Biosciences Inc.$1.4BCRISISQ 32$95.01-3.81%
- ORICSELLORIC Pharmaceuticals, Inc.$1.2BBEARQ 3$11.99-4.23%
- TRMLTourmaline Bio, Inc.$1.2B$47.98
- NKTRSELLNektar Therapeutics$1.2BCRISISQ 12$41.17-4.82%
- IMTXSELLImmatics N.V.$996MCRISISQ 5$7.43-5.27%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 7
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-8.2%
REV YoY-
ROE-13.6%
EPS YoY-
ROA-7.1%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-68.77
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B4.90
P/FCF-
EV/EBITDA-67.82
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.09
ALTMAN Z-
CURR RATIO62.41
ND/EBITDA-
BETA-0.38
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on TERN?
- LOPJLB’s latest quantitative signal on Terns Pharmaceuticals, Inc. (TERN) is BUY in a BULL regime. Signals are updated daily.
- What market regime is TERN in?
- Terns Pharmaceuticals, Inc. (TERN) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Terns Pharmaceuticals, Inc. (TERN) do?
- Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor…